Sarath Samarage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarath Samarage has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Nilmini Wijemunige
Institute for Health Policy, Colombo, Sri Lanka
3 shared publications - Ravindra Prasan Rannan-Eliya
Institute for Health Policy, Colombo, Sri Lanka
3 shared publications - Anuji Gamage
General Sir John Kotelawala Defence University
2 shared publications - Herath Mudiyanselage Meththananada Herath
University of Ruhuna
2 shared publications - Prasadini Perera
University of Peradeniya
2 shared publications Shanti Dalpatadu
Institute for Health Policy (IHP) , Colombo, Sri Lanka
2 shared publications
Latest Publications
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile: The Sri Lanka Health and Ageing Study (SLHAS)
Sri Lanka’s population is ageing with the elderly share of its population rapidly increasing. The country is also experiencing rapid epidemiological transition, with its mortality pattern now dominated by non-communicable diseases (NCDs), more similar to Europe than the rest of its region, 1 and life expectancy of 77 years close to that of the USA (78 years). 2 Access to health care services, at levels more comparable to high-income countries (HICs) than other developing countries, has contributed to these transitions, despite Sri Lanka still being a lower-middle-income country (LMIC) with inadequate social protection. 3 The experience of demographically advanced HICs provides pointers to future trends and potential responses, but Sri Lanka faces two added challenges. First, like some other Asian populations, population ageing is associated with a rising epidemic of diabetes and other metabolic disorders at younger ages and levels of body weight, the aetiology of which is not well understood. 4, 5 Second, this is occurring at lower levels of income and with inadequate government taxation. 1
- 14 February 2024
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 53 (2)
Cohort Profile: The Sri Lanka Health and Ageing Study (SLHAS)
Sri Lanka’s population is ageing with the elderly share of its population rapidly increasing. The country is also experiencing rapid epidemiological transition, with its mortality pattern now dominated by non-communicable diseases (NCDs), more similar to Europe than the rest of its region, 1 and life expectancy of 77 years close to that of the USA (78 years). 2 Access to health care services, at levels more comparable to high-income countries (HICs) than other developing countries, has contributed to these transitions, despite Sri Lanka still being a lower-middle-income country (LMIC) with inadequate social protection. 3 The experience of demographically advanced HICs provides pointers to future trends and potential responses, but Sri Lanka faces two added challenges. First, like some other Asian populations, population ageing is associated with a rising epidemic of diabetes and other metabolic disorders at younger ages and levels of body weight, the aetiology of which is not well understood. 4, 5 Second, this is occurring at lower levels of income and with inadequate government taxation. 1
- Open Access
- 18 January 2024
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 6) , e013286
Sri Lanka’s COVID-19 response and maintaining health services: implications for future pandemics
This study examines how Sri Lanka, a lower-middle income country, managed its COVID-19 response and maintained health services. It draws on an extensive document review, key informant interviews and a national survey of public experience and opinion to assess what Sri Lanka did, its effectiveness and why. Owing to a strong health system and luck, Sri Lanka stopped the first wave of COVID-19 infections, and it adopted a ‘Zero-COVID’ approach with the explicit goal of stopping outbreaks. This was initially effective. Outbreaks reduced healthcare use, but with minimal impact on health outcomes. But from end-2020, Sri Lanka switched its approach to tolerating transmission and mitigation. It took proactive actions to maintain healthcare access, and it pursued a COVID-19 vaccination effort that was successful in covering its adult population rapidly and with minimal disparities. Despite this, widespread transmission during 2021–2022 disrupted health services through the pressure on health facilities of patients with COVID-19 and infection of healthcare workers, and because COVID-19 anxiety discouraged patients from seeking healthcare. This led to substantial mortality and more than 30 000 excess deaths by 2022. We find that Sri Lanka abandoned its initially successful approach, because it failed to understand that its chosen strategy required symptomatic PCR testing in primary care. Failure to invest in testing was compounded by groupthink and a medical culture averse to testing. Sri Lanka’s experience confirms that strong public health capacities, robust healthcare systems and intersectoral action are critical for pandemic response. It shows that civilian–military collaboration can be beneficial but contested, and that lack of fiscal space will undermine any response. It also demonstrates that pandemic preparedness cannot guarantee a successful pandemic response. Policy and research must pay more attention to improving decision-making processes when faced with pandemics involving novel pathogens, rapid spread, and substantial scientific uncertainty.
- 18 January 2024
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 6) , e013286
Open AccessSri Lanka’s COVID-19 response and maintaining health services: implications for future pandemics
This study examines how Sri Lanka, a lower-middle income country, managed its COVID-19 response and maintained health services. It draws on an extensive document review, key informant interviews and a national survey of public experience and opinion to assess what Sri Lanka did, its effectiveness and why. Owing to a strong health system and luck, Sri Lanka stopped the first wave of COVID-19 infections, and it adopted a ‘Zero-COVID’ approach with the explicit goal of stopping outbreaks. This was initially effective. Outbreaks reduced healthcare use, but with minimal impact on health outcomes. But from end-2020, Sri Lanka switched its approach to tolerating transmission and mitigation. It took proactive actions to maintain healthcare access, and it pursued a COVID-19 vaccination effort that was successful in covering its adult population rapidly and with minimal disparities. Despite this, widespread transmission during 2021–2022 disrupted health services through the pressure on health facilities of patients with COVID-19 and infection of healthcare workers, and because COVID-19 anxiety discouraged patients from seeking healthcare. This led to substantial mortality and more than 30 000 excess deaths by 2022. We find that Sri Lanka abandoned its initially successful approach, because it failed to understand that its chosen strategy required symptomatic PCR testing in primary care. Failure to invest in testing was compounded by groupthink and a medical culture averse to testing. Sri Lanka’s experience confirms that strong public health capacities, robust healthcare systems and intersectoral action are critical for pandemic response. It shows that civilian–military collaboration can be beneficial but contested, and that lack of fiscal space will undermine any response. It also demonstrates that pandemic preparedness cannot guarantee a successful pandemic response. Policy and research must pay more attention to improving decision-making processes when faced with pandemics involving novel pathogens, rapid spread, and substantial scientific uncertainty.
- Open Access
- 15 February 2023
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 11 (1) , e003160
Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/2019
Introduction This study’s objective was to produce robust, comparable estimates of the prevalence of diabetes and pre-diabetes in the Sri Lankan adult population, where previous studies suggest the highest prevalence in South Asia. Research design and methods We used data on 6661 adults from the nationally representative 2018/2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS). We classified glycemic status based on previous diabetes diagnosis, and either fasting plasma glucose (FPG), or FPG and 2-hour plasma glucose (2-h PG). We estimated crude and age-standardized prevalence of pre-diabetes and diabetes and by major individual characteristics weighting the data to account for study design and subject participation. Results Crude prevalence of diabetes in adults was 23.0% (95% CI 21.2% to 24.7%) using both 2-h PG and FPG, and age-standardized prevalence was 21.8% (95% CI 20.1% to 23.5%). Using only FPG, prevalence was 18.5% (95% CI 7.1% to 19.8%). Previously diagnosed prevalence was 14.3% (95% CI 13.1% to 15.5%) of all adults. The prevalence of pre-diabetes was 30.5% (95% CI 28.2% to 32.7%). Diabetes prevalence increased with age until ages ≥70 years and was more prevalent in female, urban, more affluent, and Muslim adults. Diabetes and pre-diabetes prevalence increased with body mass index (BMI) but was as high as 21% and 29%, respectively, in those of normal weight. Conclusions Study limitations included using only a single visit to assess diabetes, relying on self-reported fasting times, and unavailability of glycated hemoglobin for most participants. Our results indicate that Sri Lanka has a very high diabetes prevalence, significantly higher than previous estimates of 8%–15% and higher than current global estimates for any other Asian country. Our results have implications for other populations of South Asian origin, and the high prevalence of diabetes and dysglycemia at normal body weight indicates the need for further research to understand the underlying drivers.
- 15 February 2023
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 11 (1) , e003160
Open AccessPrevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/2019
Introduction This study’s objective was to produce robust, comparable estimates of the prevalence of diabetes and pre-diabetes in the Sri Lankan adult population, where previous studies suggest the highest prevalence in South Asia. Research design and methods We used data on 6661 adults from the nationally representative 2018/2019 first wave of the Sri Lanka Health and Ageing Study (SLHAS). We classified glycemic status based on previous diabetes diagnosis, and either fasting plasma glucose (FPG), or FPG and 2-hour plasma glucose (2-h PG). We estimated crude and age-standardized prevalence of pre-diabetes and diabetes and by major individual characteristics weighting the data to account for study design and subject participation. Results Crude prevalence of diabetes in adults was 23.0% (95% CI 21.2% to 24.7%) using both 2-h PG and FPG, and age-standardized prevalence was 21.8% (95% CI 20.1% to 23.5%). Using only FPG, prevalence was 18.5% (95% CI 7.1% to 19.8%). Previously diagnosed prevalence was 14.3% (95% CI 13.1% to 15.5%) of all adults. The prevalence of pre-diabetes was 30.5% (95% CI 28.2% to 32.7%). Diabetes prevalence increased with age until ages ≥70 years and was more prevalent in female, urban, more affluent, and Muslim adults. Diabetes and pre-diabetes prevalence increased with body mass index (BMI) but was as high as 21% and 29%, respectively, in those of normal weight. Conclusions Study limitations included using only a single visit to assess diabetes, relying on self-reported fasting times, and unavailability of glycated hemoglobin for most participants. Our results indicate that Sri Lanka has a very high diabetes prevalence, significantly higher than previous estimates of 8%–15% and higher than current global estimates for any other Asian country. Our results have implications for other populations of South Asian origin, and the high prevalence of diabetes and dysglycemia at normal body weight indicates the need for further research to understand the underlying drivers.